Holt Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,630
| Closed | -$236K | – | 142 |
|
|
2019
Q4 | $236K | Sell |
3,630
-1,345
| -27% | -$87.4K | 0.06% | 138 |
|
|
2019
Q3 | $315K | Sell |
4,975
-420
| -8% | -$26.6K | 0.09% | 116 |
|
|
2019
Q2 | $364K | Sell |
5,395
-45
| -0.8% | -$3.04K | 0.1% | 114 |
|
|
2019
Q1 | $354K | Sell |
5,440
-645
| -11% | -$42K | 0.1% | 112 |
|
|
2018
Q4 | $381K | Sell |
6,085
-1,360
| -18% | -$85.2K | 0.12% | 104 |
|
|
2018
Q3 | $575K | Sell |
7,445
-180
| -2% | -$13.9K | 0.16% | 94 |
|
|
2018
Q2 | $540K | Sell |
7,625
-55
| -0.7% | -$3.9K | 0.16% | 96 |
|
|
2018
Q1 | $579K | Buy |
7,680
+100
| +1% | +$7.54K | 0.18% | 89 |
|
|
2017
Q4 | $543K | Sell |
7,580
-100
| -1% | -$7.16K | 0.17% | 92 |
|
|
2017
Q3 | $622K | Sell |
7,680
-200
| -3% | -$16.2K | 0.2% | 80 |
|
|
2017
Q2 | $558K | Hold |
7,880
| – | – | 0.19% | 85 |
|
|
2017
Q1 | $535K | Buy |
7,880
+360
| +5% | +$24.4K | 0.19% | 89 |
|
|
2016
Q4 | $539K | Sell |
7,520
-560
| -7% | -$40.1K | 0.2% | 88 |
|
|
2016
Q3 | $639K | Buy |
8,080
+170
| +2% | +$13.4K | 0.25% | 80 |
|
|
2016
Q2 | $660K | Buy |
7,910
+165
| +2% | +$13.8K | 0.27% | 71 |
|
|
2016
Q1 | $711K | Hold |
7,745
| – | – | 0.31% | 65 |
|
|
2015
Q4 | $784K | Sell |
7,745
-40
| -0.5% | -$4.05K | 0.35% | 58 |
|
|
2015
Q3 | $764K | Buy |
7,785
+20
| +0.3% | +$1.96K | 0.32% | 57 |
|
|
2015
Q2 | $909K | Sell |
7,765
-145
| -2% | -$17K | 0.37% | 56 |
|
|
2015
Q1 | $776K | Buy |
+7,910
| New | +$776K | 0.32% | 58 |
|